Kennedy Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Kennedy Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.91M	Buy	+1,107,379	New	+$4.78M	0.12%	269
2024 Q4	–	Sell	-66,125	Closed	-$549K	–	714
2024 Q3	$549K	Sell	66,125 -21,223	-24%	-$183K	0.01%	632
2024 Q2	$625K	Sell	87,348 -9,929	-10%	-$85.7K	0.01%	627
2024 Q1	$843K	Sell	97,277 -7,268	-7%	-$49.2K	0.02%	631
2023 Q4	$685K	Sell	104,545 -164	-0.2%	-$1.06K	0.02%	615
2023 Q3	$1.05M	Buy	+104,709	New	+$1.15M	0.03%	559

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Kennedy Capital Management's MRVI Position: Q2 2026 in Review

Kennedy Capital Management opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 1,107,379 shares worth $6.91M. The stake represents 0.12% of the portfolio and ranks #269 among its holdings. This is a return to the name: Kennedy Capital Management previously reported a position in MRVI as recently as Q3 2024.

Kennedy Capital Management first reported a position in MRVI in Q3 2023 and has held it in 6 quarters since. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Kennedy Capital Management held 1,107,379 shares of Maravai LifeSciences worth $6.91M as of Q2 2026.
Maravai LifeSciences was a new Kennedy Capital Management position in Q2 2026.
Maravai LifeSciences made up 0.12% of Kennedy Capital Management's portfolio in Q2 2026, its #269 holding.
Kennedy Capital Management first reported a position in Maravai LifeSciences in Q3 2023 and has held it in 6 quarters since.
178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.